The Rest Of Asia Pacific Negative Pressure Wound Therapy Market was valued at $28.47 Million in 2025 and projected to reach to $45.24 Million by 2030, representing a compound annual growth rate of 9.7%. Rest Of Asia Pacific represents a high-growth opportunity in the global Negative Pressure Wound Therapy market, with expansion driven by rising chronic disease burden, improving healthcare accessibility, and increasing awareness of advanced wound management solutions.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Rest Of Asia Pacific's Negative Pressure Wound Therapy market is growing at 9.7% CAGR, significantly outpacing the global rate of 6.9%, reflecting strong regional demand and market maturation.
Market valuation is projected to increase from USD 28.47 million in 2025 to USD 45.24 million by 2030, representing a 59% growth opportunity over the five-year forecast period.
Rising healthcare infrastructure investments across Rest Of Asia Pacific countries are enabling wider adoption of advanced wound therapy technologies and improving patient access to NPWT solutions.
Increasing prevalence of chronic wounds, diabetic ulcers, and post-surgical complications in Rest Of Asia Pacific is driving demand for effective negative pressure wound therapy treatments.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | HOSPITALS (End User) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 6.9% from 2025 to 2030 |
| Largest Segment | CONVENTIONAL NPWT DEVICES (Product Type) |
| Market Size Base Year (Billions) | ~USD 2.75 (2025) |
| Revenue Forecast (Billions) | ~USD 3.84 (2030) |
| Segments Covered | Product Type, Wound Type, End User |
3 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| NITTO DENKO CORPORATION | Japan | Public Company | Conventional NPWT (materials content),Single-use NPWT (materials content),NPWT Consumables (dressings, drapes, tapes), |
| COLOPLAST A/S | Denmark | Public Company | Conventional NPWT systems,Single-use NPWT,Consumables, |
| SOLVENTUM | United States | Public Company | Conventional NPWT Systems,Single-use NPWT,Consumables (Dressings, Canisters, Interfaces), |
| SMITH+NEPHEW | United Kingdom | Public Company | Conventional NPWT Systems,Single-use NPWT Systems,Consumables (Dressings & Canisters), |
| CARDINAL HEALTH | United States | Public Company | Conventional NPWT Systems,Single-use NPWT,Consumables, |
| MöLNLYCKE AB | Sweden | Private Company | Conventional NPWT,Single-use NPWT,Consumables, |
| CONVATEC GROUP PLC | United Kingdom | Public Company | Conventional NPWT Systems,Single-use NPWT,Consumables (Dressings, Canisters, Tubing), |
| PAUL HARTMANN AG | Germany | Public Company | Conventional NPWT systems,Single-use NPWT,NPWT Consumables (dressings, canisters, tubing), |
| AVERY DENNISON CORPORATION | United States | Public Company | Conventional NPWT (materials inputs),Single-use NPWT (materials inputs),Consumables (dressings, drapes, interface materials), |
| BENQ MATERIALS CORPORATION | Taiwan | Public Company | Conventional NPWT systems,Single-use NPWT,NPWT consumables (dressings, drapes, canisters), |
| DOUBLE MEDICAL TECHNOLOGY INC. | China | Public Company | Conventional NPWT Systems,Single-use NPWT,Consumables (Dressings & Canisters), |
Nitto Denko Corporation is a Japanese public company founded in 1918 with 26,477 employees. The company operates as a diversified manufacturer with operations across multiple industrial sectors.
Coloplast A/S is a Danish public company established in 1954 with 17,083 employees. The company specializes in medical devices and healthcare solutions.
Solventum is a United States public company established in 2023 with 20,584 employees. The company operates in the healthcare and industrial sectors.
Smith+Nephew is a United Kingdom-based public company founded in 1856 with 16,988 employees. The company is a global medical technology provider specializing in orthopedics, wound care, and surgical products.
Cardinal Health is a United States public company founded in 1979 with 55,392 employees. The company is a major healthcare services and products distributor serving hospitals, pharmacies, and other healthcare providers.
Mölnlycke AB is a Swedish private company established in 1849 with 8,463 employees. The company specializes in healthcare and hygiene products.
ConvaTec Group PLC is a United Kingdom-based public company founded in 1978 with 10,910 employees. The company develops and manufactures medical devices and products for ostomy care, continence care, and wound care.
Paul Hartmann AG is a German public company founded in 1818 with 10,066 employees. The company produces medical and hygiene products for healthcare and consumer markets.
Avery Dennison Corporation is a United States public company founded in 1935 with 35,000 employees. The company manufactures pressure-sensitive materials, labels, and packaging solutions for various industries.
BenQ Materials Corporation is a Taiwan-based public company founded in 1998 with 1,317 employees. The company manufactures specialty materials and components.
Double Medical Technology Inc. is a China-based public company founded in 2004 with 4,704 employees. The company manufactures medical devices and healthcare products.
Rest Of Asia Pacific's NPWT market is estimated at USD 28.47 million in 2025 and is projected to reach USD 45.24 million by 2030.
Rest Of Asia Pacific's NPWT market is expected to grow at a compound annual growth rate of 9.7% from 2025 to 2030.
Rest Of Asia Pacific's 9.7% CAGR significantly outpaces the global CAGR of 6.9%, indicating stronger regional market momentum and adoption potential.
Rest Of Asia Pacific's market growth is driven by increasing chronic wound prevalence, expanding healthcare infrastructure, rising surgical volumes, and improved clinical awareness among providers.
Rest Of Asia Pacific includes emerging and developing economies within the Asia Pacific region excluding major markets like China, Japan, India, and Australia.
The study involved major activities in estimating the current market size for the negative pressure wound therapy market. Exhaustive secondary research was done to collect information on the negative pressure wound therapy industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the negative pressure wound therapy market.
The four steps involved in estimating the market size are:
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), , Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global negative pressure wound therapy market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the negative pressure wound therapy market. The primary sources from the demand side include pharmaceutical companies, biotechnology companies, CROs, pharmacies, medical device companies, and research academics and universities. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.
The following is a breakdown of the primary respondents:
Note 1: Other designations include sales managers, marketing managers, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global negative pressure wound therapy market. All the major service providers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. The global negative pressure wound therapy market was split into various segments and sub-segments based on:
The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.
The research methodology used to estimate the market size includes the following:

After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Negative pressure wound therapy is a treatment that pulls fluid and bacteria out of a wound to help it heal better. Some healthcare providers call it vacuum-assisted therapy. It works by creating suction. A provider can use this treatment to heal soft tissue on many different parts of your body.
Full forecast, segment splits, and company analysis for all Negative Pressure Wound Therapy Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report